journal article·2017-02-13

Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants

Sema Sevimli, Frances C. Knight, Pavlo Gilchuk, Sebastian Joyce, John T. Wilson

Publisher page

Abstract

Vaccine design has undergone a shift toward the use of purified protein subunit vaccines, which offer increased safety and greater control over antigen specificity, but at the expense of immunogenicity. Here we report the development of a new polymer-based vaccine delivery platform engineered to enhance immunity through the codelivery of protein antigens and the Toll-like receptor 7 (TLR7) agonist imiquimod (IMQ). Because of the preferential solubility of IMQ in fatty acids, a series of block copolymer micelles with a fatty acid-mimetic core comprising lauryl methacrylate (LMA) and methacrylic acid (MAA), and a poly(ethylene glycol) methyl ether methacrylate (PEGMA) corona decorated with pyridyl disulfide ethyl methacrylate (PDSM) moieties for antigen conjugation were synthesized via reversible addition–fragmentation chain transfer (RAFT) polymerization. Carriers composed of 50 mol % LMA (LMA50) demonstrated the highest IMQ loading (2.2 w/w%) and significantly enhanced the immunostimulatory capacity of IMQ to induce dendritic cell maturation and proinflammatory cytokine production. Conjugation of a model antigen, ovalbumin (OVA), to the corona of IMQ-loaded LMA50 micelles enhanced in vitro antigen uptake and cross-presentation on MHC class I (MHC-I). A single intranasal (i.n.) immunization of mice with carriers coloaded with IMQ and OVA elicited significantly higher pulmonary and systemic CD8 + T cell responses and increased serum IgG titer relative to a soluble formulation of antigen and adjuvant. Collectively, these data demonstrate that rationally designed fatty acid-mimetic micelles enhance intracellular antigen and IMQ delivery, and have potential as synthetic vectors for enhancing the immunogenicity of subunit vaccines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Monoclonal and Polyclonal Antibodies Research · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biomolecular Engineering, Vanderbilt University, 2400 Highland Avenue, Nashville, Tennessee 37235, United States

Department of Biomedical Engineering, Vanderbilt University, 2301 Vanderbilt Place, Nashville, Tennessee 37235, United States

Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Medical Center North, Nashville, Tennessee 37232, United States

Department of Veterans Administration Tennessee Valley Healthcare System, 1310 24th Avenue South, Nashville, Tennessee 37212, United States

Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, 2301 Vanderbilt Place, Nashville, Tennessee 37235, United States

Funding

Vanderbilt University · U.S. Department of Veterans Affairs · National Institute of Allergy and Infectious Diseases · Division of Chemical, Bioengineering, Environmental, and Transport Systems · School of Engineering, Vanderbilt University

References (96)

Show source-provided references
1. 10.1038/nature1012410.1038/nature10124 ↗
2. 10.1056/NEJMra120418610.1056/NEJMra1204186 ↗
3. 10.1038/nm.340910.1038/nm.3409 ↗
4. 10.1016/j.immuni.2010.10.00210.1016/j.immuni.2010.10.002 ↗
5. 10.1016/j.ijpharm.2008.04.03610.1016/j.ijpharm.2008.04.036 ↗
6. 10.1038/nri251010.1038/nri2510 ↗
7. 10.1016/j.coi.2010.04.00210.1016/j.coi.2010.04.002 ↗
8. 10.1016/j.ejps.2011.08.01610.1016/j.ejps.2011.08.016 ↗
9. 10.1586/14760584.2013.81118510.1586/14760584.2013.811185 ↗
10. 10.1038/ni111210.1038/ni1112 ↗
11. 10.1038/nri347910.1038/nri3479 ↗
12. 10.1038/ni.186310.1038/ni.1863 ↗
13. 10.3390/vaccines202032310.3390/vaccines2020323 ↗
14. 10.1111/j.1600-065X.2008.00604.x10.1111/j.1600-065X.2008.00604.x ↗
15. 10.1073/pnas.040093710110.1073/pnas.0400937101 ↗
16. 10.1038/ni75810.1038/ni758 ↗
17. 10.1128/IAI.00974-0810.1128/IAI.00974-08 ↗
18. 10.1038/nbt.337110.1038/nbt.3371 ↗
19. 10.1586/14760584.2013.81120810.1586/14760584.2013.811208 ↗
20. 10.1111/ijd.1323510.1111/ijd.13235 ↗
21. 10.1080/1083745990898422210.1080/10837459908984222 ↗
22. 10.5414/CPP3847610.5414/CPP38476 ↗
23. 10.1073/pnas.160081611310.1073/pnas.1600816113 ↗
24. 10.1158/1078-0432.CCR-07-144310.1158/1078-0432.CCR-07-1443 ↗
25. 10.1038/bjc.1996.56910.1038/bjc.1996.569 ↗
26. 10.1038/sj.onc.121091310.1038/sj.onc.1210913 ↗
27. 10.1016/j.jhep.2007.02.02510.1016/j.jhep.2007.02.025 ↗
28. 10.1126/scitranslmed.300998010.1126/scitranslmed.3009980 ↗
29. 10.1021/mp900311x10.1021/mp900311x ↗
30. 10.1021/mp400092y10.1021/mp400092y ↗
31. 10.1038/nature0973710.1038/nature09737 ↗
32. 10.1016/j.biomaterials.2014.05.07610.1016/j.biomaterials.2014.05.076 ↗
33. 10.1021/nn305466z10.1021/nn305466z ↗
34. 10.1038/nmat296010.1038/nmat2960 ↗
35. 10.1021/acsbiomaterials.5b0037510.1021/acsbiomaterials.5b00375 ↗
36. 10.1016/j.jconrel.2012.10.02010.1016/j.jconrel.2012.10.020 ↗
37. 10.1016/j.jconrel.2013.09.01210.1016/j.jconrel.2013.09.012 ↗
38. 10.1016/j.biomaterials.2013.10.00910.1016/j.biomaterials.2013.10.009 ↗
39. 10.1038/nbt133210.1038/nbt1332 ↗
40. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
41. 10.1016/j.ejpb.2004.10.00610.1016/j.ejpb.2004.10.006 ↗
42. 10.1186/1477-3155-12-1710.1186/1477-3155-12-17 ↗
43. 10.1016/j.jconrel.2014.03.04110.1016/j.jconrel.2014.03.041 ↗
44. 10.1208/s12248-014-9697-110.1208/s12248-014-9697-1 ↗
45. 10.1016/j.vaccine.2010.09.07710.1016/j.vaccine.2010.09.077 ↗
46. 10.1021/bk-2015-1187.ch01210.1021/bk-2015-1187.ch012 ↗
47. 10.1071/CH0507210.1071/CH05072 ↗
48. 10.1021/ma100221y10.1021/ma100221y ↗
49. 10.1021/bm800197v10.1021/bm800197v ↗
50. 10.1021/la504378m10.1021/la504378m ↗
51. 10.1016/j.jconrel.2012.07.04210.1016/j.jconrel.2012.07.042 ↗
52. 10.1039/c2py20112g10.1039/c2py20112g ↗
53. 10.1016/S1074-7613(00)80447-110.1016/S1074-7613(00)80447-1 ↗
54. 10.1002/jps.2226710.1002/jps.22267 ↗
55. Gilchuk P. · 2017 · 32110.1007/978-1-4939-6445-1_25 ↗
56. 10.1038/nprot.2006.12110.1038/nprot.2006.121 ↗
57. 10.1021/bm300846e10.1021/bm300846e ↗
58. 10.1073/pnas.100604410710.1073/pnas.1006044107 ↗
59. 10.1038/mt.2015.2210.1038/mt.2015.22 ↗
60. 10.1021/bc100204m10.1021/bc100204m ↗
61. 10.1002/pola.1088510.1002/pola.10885 ↗
62. 10.1021/ma051380h10.1021/ma051380h ↗
63. 10.1002/1521-3935(20010401)202:7<1138::AID-MACP1138>3.0.CO;2-110.1002/1521-3935(20010401)202:7<1138::AID-MACP1138>3.0.CO;2-1 ↗
64. 10.1023/A:101590382704210.1023/A:1015903827042 ↗
65. 10.1002/mabi.20100029310.1002/mabi.201000293 ↗
66. 10.1021/ma801823810.1021/ma8018238 ↗
67. 10.3390/ma202063610.3390/ma2020636 ↗
68. 10.1021/acsami.5b0642710.1021/acsami.5b06427 ↗
69. 10.1021/bm100652w10.1021/bm100652w ↗
70. 10.1016/j.molliq.2012.10.01310.1016/j.molliq.2012.10.013 ↗
71. 10.1039/c2sm27189c10.1039/c2sm27189c ↗
72. 10.1039/c1py00094b10.1039/c1py00094b ↗
73. 10.2217/nnm.10.1010.2217/nnm.10.10 ↗
74. 10.1002/mabi.20130010210.1002/mabi.201300102 ↗
75. 10.1016/j.biomaterials.2013.02.04910.1016/j.biomaterials.2013.02.049 ↗
76. 10.1039/c3ay40239h10.1039/c3ay40239h ↗
77. 10.1016/j.biomaterials.2016.01.06110.1016/j.biomaterials.2016.01.061 ↗
78. 10.1007/s11095-014-1465-510.1007/s11095-014-1465-5 ↗
79. 10.1002/pola.2455310.1002/pola.24553 ↗
80. 10.1038/cmi.2010.3010.1038/cmi.2010.30 ↗
81. Testerman T. L. · J. Leukocyte Biol. · 1995 · 58 · 36510.1002/jlb.58.3.365 ↗
82. 10.1042/bj116055510.1042/bj1160555 ↗
83. 10.1002/adma.20120044610.1002/adma.201200446 ↗
84. 10.1016/j.coi.2009.12.00510.1016/j.coi.2009.12.005 ↗
85. 10.1182/blood-2006-04-01571910.1182/blood-2006-04-015719 ↗
86. 10.1016/j.vaccine.2009.07.06210.1016/j.vaccine.2009.07.062 ↗
87. 10.4049/jimmunol.100189210.4049/jimmunol.1001892 ↗
88. Shen Z. · J. Immunol. · 1997 · 158 · 272310.4049/jimmunol.158.6.2723 ↗
89. 10.1038/mi.2012.9610.1038/mi.2012.96 ↗
90. 10.1038/ni.305610.1038/ni.3056 ↗
91. 10.1146/annurev-bioeng-071811-15005410.1146/annurev-bioeng-071811-150054 ↗
92. 10.1016/j.celrep.2016.07.03710.1016/j.celrep.2016.07.037 ↗
93. 10.1002/eji.20104056210.1002/eji.201040562 ↗
94. 10.1182/blood-2011-04-34883910.1182/blood-2011-04-348839 ↗
95. 10.1038/ncomms567410.1038/ncomms5674 ↗
96. 10.2174/18715281280358996710.2174/187152812803589967 ↗